Another Philadelphia jury has decided that drugmaker Wyeth should be punished with punitive damages for the warnings provided to a plaintiff and her doctor over the risk of breast cancer from Wyeth’s hormonal drug Prempro.

The jury awarded $6 million in punitive damages and $3.45 million in compensatory damages Monday in Singleton v. Wyeth. According to plaintiffs’ counsel Zoe Littlepage of Littlepage Booth in Houston, this case is the first in the country involving a plaintiff diagnosed with breast cancer well after the July 2002 release of the Women’s Health Initiative, a randomized, controlled trial of the risks and benefits of hormone replacement.